References
- Bartel DP. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116(2):281–297. doi: https://doi.org/10.1016/S0092-8674(04)00045-5
- Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, et al. 2017. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 135(10):e146–e603. doi: https://doi.org/10.1161/CIR.0000000000000485
- Dai GH, Ma PZ, Song XB, Liu N, Zhang T, Wu B, Ahrens I. 2014. MicroRNA-223-3p inhibits the angiogenesis of ischemic cardiac microvascular endothelial cells via affecting RPS6KB1/hif-1a signal pathway. PLoS One. 9(10):e108468. doi: https://doi.org/10.1371/journal.pone.0108468
- Das S, Halushka MK. 2015. Extracellular vesicle microRNA transfer in cardiovascular disease. Cardiovasc Pathol. 24(4):199–206. doi: https://doi.org/10.1016/j.carpath.2015.04.007
- Desta L, Jernberg T, Lofman I, Hofman-Bang C, Hagerman I, Spaak J, Persson H. 2015. Incidence, temporal trends, and prognostic impact of heart failure complicating acute myocardial infarction. The SWEDEHEART Registry (Swedish web-system for enhancement and development of evidence-based care in heart disease evaluated according to recommended therapies): a study of 199,851 patients admitted with index acute myocardial infarctions, 1996 to 2008. JACC Heart Fail. 3(3):234–242. doi: https://doi.org/10.1016/j.jchf.2014.10.007
- Dreyer RP, Sciria C, Spatz ES, Safdar B, D’Onofrio G, Krumholz HM. 2017. Young women with acute myocardial infarction: current perspectives. Circ Cardiovasc Qual Outcomes. 10(2):e003480. https://pubmed.ncbi.nlm.nih.gov/28228455/. doi: https://doi.org/10.1161/CIRCOUTCOMES.116.003480
- Jia Z, Wang J, Shi Q, Liu S, Wang W, Tian Y, Lu Q, Chen P, Ma K, Zhou C. 2016. SOX6 and PDCD4 enhance cardiomyocyte apoptosis through LPS-induced miR-499 inhibition. Apoptosis. 21(2):174–183. doi: https://doi.org/10.1007/s10495-015-1201-6
- Katarzyna R. 2017. Adult stem cell therapy for cardiac repair in patients after acute myocardial infarction leading to ischemic heart failure: an overview of evidence from the recent clinical trials. Curr Cardiol Rev. 13(3):223–231. doi: https://doi.org/10.2174/1573403X13666170502103833
- Lal H, Ahmad F, Parikh S, Force T. 2014. Troponin I-interacting protein kinase: a novel cardiac-specific kinase, emerging as a molecular target for the treatment of cardiac disease. Circ J. 78(7):1514–1519. doi: https://doi.org/10.1253/circj.CJ-14-0543
- Lesizza P, Prosdocimo G, Martinelli V, Sinagra G, Zacchigna S, Giacca M. 2017. Single-dose intracardiac injection of pro-regenerative microRNAs improves cardiac function after myocardial infarction. Circ Res. 120(8):1298–1304. doi: https://doi.org/10.1161/CIRCRESAHA.116.309589
- Li C, Fang Z, Jiang T, Zhang Q, Liu C, Zhang C, Xiang Y. 2013. Serum microRNAs profile from genome-wide serves as a fingerprint for diagnosis of acute myocardial infarction and angina pectoris. BMC Med Genomics. 6:16. doi: https://doi.org/10.1186/1755-8794-6-16
- Liu W, Ling S, Sun W, Liu T, Li Y, Zhong G, Zhao D, Zhang P, Song J, Jin X, et al. 2015. Circulating microRNAs correlated with the level of coronary artery calcification in symptomatic patients. Sci Rep. 5:16099. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633594/. doi: https://doi.org/10.1038/srep16099
- Liu X, Zhang Y, Du W, Liang H, He H, Zhang L, Pan Z, Li X, Xu C, Zhou Y, et al. 2016. MiR-223-3p as a novel microRNA regulator of expression of voltage-gated K+ channel Kv4.2 in acute myocardial infarction. Cell Physiol Biochem. 39(1):102–114. doi: https://doi.org/10.1159/000445609
- Mehta LS, Beckie TM, DeVon HA, Grines CL, Krumholz HM, Johnson MN, Lindley KJ, Vaccarino V, Wang TY, Watson KE, et al. 2016. Acute myocardial infarction in women: a scientific statement from the American Heart Association. Circulation. 133(9):916–947. doi: https://doi.org/10.1161/CIR.0000000000000351
- Mihalko E, Huang K, Sproul E, Cheng K, Brown AC. 2018. Targeted treatment of ischemic and fibrotic complications of myocardial infarction using a dual-delivery microgel therapeutic. ACS Nano. 12(8):7826–7837. doi: https://doi.org/10.1021/acsnano.8b01977
- Qian L, Van Laake LW, Huang Y, Liu S, Wendland MF, Srivastava D. 2011. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med. 208(3):549–560. doi: https://doi.org/10.1084/jem.20101547
- Rodriguez AE, Hernandez JA, Benito R, Gutierrez NC, Garcia JL, Hernandez-Sanchez M, Risueno A, Sarasquete ME, Ferminan E, Fisac R, et al. 2012. Molecular characterization of chronic lymphocytic leukemia patients with a high number of losses in 13q14. PLoS One. 7(11):e48485. doi: https://doi.org/10.1371/journal.pone.0048485
- Schirle NT, Sheu-Gruttadauria J, MacRae IJ. 2014. Structural basis for microRNA targeting. Science. 346(6209):608–613. doi: https://doi.org/10.1126/science.1258040
- Townsend N, Wilson L, Bhatnagar P, Wickramasinghe K, Rayner M, Nichols M. 2016. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 37(42):3232–3245. doi: https://doi.org/10.1093/eurheartj/ehw334
- van Berlo JH, Molkentin JD. 2016. Most of the dust has settled: cKit+ progenitor cells are an irrelevant source of cardiac myocytes in vivo. Circ Res. 118(1):17–19. doi: https://doi.org/10.1161/CIRCRESAHA.115.307934
- van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN. 2008. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A. 105(35):13027–13032. doi: https://doi.org/10.1073/pnas.0805038105
- Wang YS, Zhou J, Hong K, Cheng XS, Li YG. 2015. MicroRNA-223 displays a protective role against cardiomyocyte hypertrophy by targeting cardiac troponin I-interacting kinase. Cell Physiol Biochem. 35(4):1546–1556. doi: https://doi.org/10.1159/000373970